HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 2,105.00
-15.00 (-0.71%)
Sep 1, 2026, 3:30 PM KST
HLB Therapeutics Market Cap
HLB Therapeutics has a market cap or net worth of 196.24 billion as of September 1, 2026. Its market cap has decreased by -24.13% in one year.
Market Cap
196.24B
Enterprise Value
248.51B
Revenue
64.45B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,105.00
ChartMarket Cap Chart
Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 196.24B, an increase of 85.48%. That is a compound annual growth rate of 3.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 196.24B | -22.09% |
| Dec 30, 2025 | 251.87B | -73.05% |
| Dec 30, 2024 | 934.49B | 182.02% |
| Dec 28, 2023 | 331.36B | -9.25% |
| Dec 29, 2022 | 365.14B | -3.64% |
| Dec 30, 2021 | 378.91B | -51.22% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Proteina | 396.16B |
| SillaJen | 360.24B |
| MEDIPOST | 350.99B |
| Genomictree | 288.19B |
| NeoImmuneTech | 248.16B |
| Bioneer | 214.48B |
| GC Cell | 202.72B |
| Anterogen.Co.,Ltd. | 148.59B |